Article

In silico elucidation revealed SARS CoV and MERS CoV Drug Compounds could be Potential Therapeutic Candidates against Post Fusion Core (S2) Protein of Novel Coronavirus (2019-nCov)

2020-03-27

Abstract excerpt

Novel coronavirus (2019-nCoV), since its emergence from Wuhan China in December 31, 2019 is still uncontrolled and has raised attention around the globe. According to World health organization, up to March 20, 2020, globally 209,839 confirmed cases of COVID-19 have been reported along with 8778 deaths. 2019-nCoV is likely to be a recombinant of different coronaviruses such as SARS CoV and MERS CoV. Recent developm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 50c35ddb-990d-5060-bf2e-5ec619091ac4
DOI: 10.21203/rs.3.rs-19589/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

In silico elucidation revealed SARS CoV and MERS CoV Drug Compounds could be Potential Therapeutic Candidates against Post Fusion Core (S2) Protein of Novel Coronavirus (2019-nCov)DOI 10.21203/rs.3.rs-19589/v1Read

Coronavirus (2019-nCoV) Deactivation via Spike Glycoprotein Shielding by Old Drugs, Bioinformatic StudySemantic proximity Read

Predictions for the binding domain and potential new drug targets of 2019-nCoVSemantic proximity Read

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike proteinSemantic proximity Read

Computational Approach for Covalent Lead Identification against Spike Glycoprotein of SARS-CoV-2Semantic proximity Read

Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design.Semantic proximity Read

Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug designSemantic proximity Read

Structure/epitope-based immunoinformatics analysis of structural proteins of 2019 novel coronavirusSemantic proximity Read

A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanismSemantic proximity Read

Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19Semantic proximity Read

Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCovSemantic proximity Read

Functional pangenome analysis suggests inhibition of the protein E as a readily available therapy for COVID-2019Semantic proximity Read

Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 PatientsSemantic proximity Read